US Stock MarketDetailed Quotes
RVPH Reviva Pharmaceuticals
- 1.800
- -0.060-3.23%
Close Dec 27 16:00 ET
- 1.810
- +0.010+0.56%
Post 19:55 ET
83.84MMarket Cap-1.67P/E (TTM)
1.920High1.710Low2.93MVolume1.870Open1.860Pre Close5.31MTurnover8.95%Turnover RatioLossP/E (Static)46.58MShares5.67052wk High-8.41P/B58.92MFloat Cap0.60052wk Low--Dividend TTM32.74MShs Float15.100Historical High--Div YieldTTM11.29%Amplitude0.530Historical Low1.814Avg Price1Lot Size
Reviva Pharmaceuticals Stock Forum
Sign in to post a comment
$Reviva Pharmaceuticals (RVPH.US)$ Reviva Announces Proposed Public Offering
GlobeNewswire· 6 mins ago
GlobeNewswire· 6 mins ago
3
4
$Reviva Pharmaceuticals (RVPH.US)$
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia
Monday, 16th December at 8:00 am
– Once daily brilaroxazine demonstrated favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year –
– Generally well-tolerated with low rates of adverse events and discontinuation –
– Full data set from open-label extension (OLE) of R...
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia
Monday, 16th December at 8:00 am
– Once daily brilaroxazine demonstrated favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year –
– Generally well-tolerated with low rates of adverse events and discontinuation –
– Full data set from open-label extension (OLE) of R...
1
$ABVC BioPharma (ABVC.US)$ - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
26
8
7
$Reviva Pharmaceuticals (RVPH.US)$Analysts Think This $3 Stock Has 430% Upside Potential - Trades Of The Day
$Reviva Pharmaceuticals (RVPH.US)$Reviva: Upcoming Events Generate Excitement, But Cash Is Low (RVPH)" data-render="ssr
$bluebird bio (BLUE.US)$ $Direxion Daily FTSE China Bear 3X Shares ETF (YANG.US)$ $New Era Helium (NEHC.US)$ $Jet.AI (JTAI.US)$ $Volato Group (SOAR.US)$ $Reviva Pharmaceuticals (RVPH.US)$ $Nanobiotix (NBTX.US)$ $Gelteq (GELS.US)$ $The Glimpse (VRAR.US)$ $Processa Pharmaceuticals (PCSA.US)$ $TNL Mediagene (TNMG.US)$ $Cumberland Pharmaceuticals (CPIX.US)$ $Chimerix (CMRX.US)$
📊⚡️📊
📊⚡️📊
4
1
$Fangdd Network (DUO.US)$ $TheRealReal (REAL.US)$ $Asset Entities (ASST.US)$ $Quantum-Si (QSI.US)$ $Reviva Pharmaceuticals (RVPH.US)$ $MDJM Ltd (UOKA.US)$ $Sonnet BioTherapeutic (SONN.US)$ $Procaps (PROC.US)$ $Gelteq (GELS.US)$ $Gaxos.ai (GXAI.US)$ $Zeo Energy (ZEO.US)$ $Metagenomi Technologies, LLC (MGX.US)$ $Huize (HUIZ.US)$ $LeddarTech (LDTC.US)$
📊⚡️📊
📊⚡️📊
8
3
$Reviva Pharmaceuticals (RVPH.US)$ why it’s on circuit breaker? any news?
2
$Mixed Martial Arts Group (MMA.US)$ $Reviva Pharmaceuticals (RVPH.US)$ $Qualigen Therapeutics (QLGN.US)$ $NOVONIX (NVX.US)$ $Medicus Pharma (MDCX.US)$ $Hepion Pharmaceuticals (HEPA.US)$ $Purple Biotech (PPBT.US)$ $Eterna Therapeutics (ERNA.US)$ $Elong Power (ELPW.US)$ $Venus Concept (VERO.US)$ $Biofrontera (BFRI.US)$ $Exicure (XCUR.US)$
📊⚡️📊
📊⚡️📊
2
1
$Reviva Pharmaceuticals (RVPH.US)$ well i gave this play out a while ago anyone knows me knows i know this ticker for past few years.. nice moves today, will read and catch up on it, volume light, market conditions not great but 40% pretty good day so far.. will be on radar next year as well
No comment yet
Heat List
US
Overall
Symbol
Price
% Chg
No Data
72641842 : incompleted blank 8k offering
Trytosaveabit OP 72641842 : They haven’t actually filed it yet! Hehehe
Trytosaveabit OP 72641842 : The price I should say! They did say how many though! Hehehe
72641842 Trytosaveabit OP : ya not the best offering but allows for cheap shares for the q1 results